NZ515912A - Fimbrial proteins - Google Patents

Fimbrial proteins

Info

Publication number
NZ515912A
NZ515912A NZ515912A NZ51591200A NZ515912A NZ 515912 A NZ515912 A NZ 515912A NZ 515912 A NZ515912 A NZ 515912A NZ 51591200 A NZ51591200 A NZ 51591200A NZ 515912 A NZ515912 A NZ 515912A
Authority
NZ
New Zealand
Prior art keywords
salmonella enterica
fimbrial proteins
enterica subspecies
fimbrial
proteins
Prior art date
Application number
NZ515912A
Other languages
English (en)
Inventor
Anders Folkesson
Staffan Normark
Sven Lofdahl
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Publication of NZ515912A publication Critical patent/NZ515912A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ515912A 1999-05-28 2000-05-26 Fimbrial proteins NZ515912A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9901961A SE9901961D0 (sv) 1999-05-28 1999-05-28 Fimbrial proteins
PCT/SE2000/001079 WO2000073336A1 (en) 1999-05-28 2000-05-26 Fimbrial proteins

Publications (1)

Publication Number Publication Date
NZ515912A true NZ515912A (en) 2004-02-27

Family

ID=20415789

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515912A NZ515912A (en) 1999-05-28 2000-05-26 Fimbrial proteins

Country Status (7)

Country Link
EP (1) EP1180118A1 (xx)
JP (1) JP2003502291A (xx)
AU (1) AU773484B2 (xx)
CA (1) CA2372250A1 (xx)
NZ (1) NZ515912A (xx)
SE (1) SE9901961D0 (xx)
WO (1) WO2000073336A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60216099D1 (de) * 2001-05-17 2006-12-28 Creatogen Ag Methode zum auffinden von abgeschwächten oder virulent-defekten mikroben
AU2009254932A1 (en) 2008-06-03 2009-12-10 Health Protection Agency Salmonella detection assay

Also Published As

Publication number Publication date
SE9901961D0 (sv) 1999-05-28
WO2000073336A1 (en) 2000-12-07
AU773484B2 (en) 2004-05-27
AU5262800A (en) 2000-12-18
JP2003502291A (ja) 2003-01-21
CA2372250A1 (en) 2000-12-07
EP1180118A1 (en) 2002-02-20

Similar Documents

Publication Publication Date Title
NO20061736L (no) Krystallform av epotilon B
NO20005672L (no) Svekkede Salmonella-mutanter som konstitutivt uttrykker Vi- antigenet
HUP0203056A1 (hu) Vakcinakészítmény
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MA26905A1 (fr) Derives de phenylglycine.
BG107220A (en) Antitumoral ecteinascudin derivatives
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
EA200201248A1 (ru) Применение lactobacillus casei в иммуностимуляторных пептидах
PL330407A1 (en) Substituted cyclopentane compounds useful as neuraminidaze inhibitors
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
CY1105490T1 (el) Χρηση αλλαντικης τοξινης για θεραπεια παθολογικων καταστασεων των αρθρωσεων
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
EA200200875A1 (ru) Пролекарства производных имидазопиридина
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
BR0009663A (pt) Composições de vacinas antibacterianas
ATE275143T1 (de) Verbindungen
TR200501541T2 (tr) Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
NZ515912A (en) Fimbrial proteins
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia
BR0016616A (pt) Microrganismos atenuados para o tratamento de infecção

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)